Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Isaac Rhea"'
Autor:
Merna Armanious, Isaac Rhea, Shreya Mishra, Mohammed Alomar, Kerry Ellenberg, Sara Khodor, Linh M. Duong, Kevin E. Kip, Anh Thy H. Nguyen, Justin Swanson, Michael G. Fradley, Matthew B. Schabath, Nirav Shah, Anant Kharod
Publikováno v:
JACC: CardioOncology
Background Atrial fibrillation (AF) is a common cardiovascular complication affecting patients with cancer, but management strategies are not well established. Objectives The purpose of this retrospective cohort study was to evaluate cross-sectional
Autor:
Syed S. Mahmood, Zsofia D. Drobni, Michael G. Fradley, Daniel A. Zlotoff, Matthew J. Frigault, Emmanuel Bassily, Jeremy S. Abramson, Malek Z.O. Hassan, Magid Awadalla, Adam Rokicki, Noopur Raje, Aleksandr Lazaryan, Raza M. Alvi, Frederick L. Locke, Dae Hyun Lee, Julio C. Chavez, Lili Zhang, Isaac Rhea, Connor P. Mulligan, Tomas G. Neilan, Bijal D. Shah, Dahlia Banerji, Michael D. Jain, Roohi Ismail-Khan
Publikováno v:
Journal of the American College of Cardiology. 74:3099-3108
Background Chimeric antigen receptors redirect T cells (CAR-T) to target cancer cells. There are limited data characterizing cardiac toxicity and cardiovascular (CV) events among adults treated with CAR-T. Objectives The purpose of this study was to
Autor:
Issa Pour-Ghaz, Anandbir Bath, Sharif Kayali, Deya Alkhatib, Neeraja Yedlapati, Isaac Rhea, Rami N. Khouzam, John L. Jefferies, Mannu Nayyar
Publikováno v:
Current Problems in Cardiology. 47:101366
Amyloidosis is a group of disorders that can affect almost any organ due to the misfolding of proteins with their subsequent deposition in various tissues, leading to various disease manifestations based on the location. When the heart is involved, a
Publikováno v:
Cardiology Clinics. 37:459-468
Multiple cancer therapies are associated with cardiac arrhythmias through a variety of pathophysiologic mechanisms. Atrial fibrillation and atrial flutter are common during cancer therapy but should rarely limit continued delivery of therapy. Ventric
Autor:
Bijal D. Shah, Matthew B. Schabath, Dae Hyun Lee, Julio C. Chavez, Federico Viganego, Howard L. McLeod, Javier Pinilla-Ibarz, Michael G. Fradley, Josephine Emole, Matthew Gliksman, Merna Armanious, Allan Welter-Frost, Christine M. Walko, Isaac Rhea
Publikováno v:
The American Journal of Cardiology. 124:539-544
There is increasing evidence that rates of atrial arrhythmias (AA), specifically atrial fibrillation and flutter are elevated in patients treated with the tyrosine kinase inhibitor, ibrutinib; however, the exact risk of ibrutinib-associated AA is not
Publikováno v:
Current oncology reports. 21(5)
Purpose of Review: The anticoagulation strategies for various cardiac-specific pathologies including atrial fibrillation are changing. Applying these strategies in patients with concomitant active cancer requires additional considerations. Here, we r
Autor:
Merna Armanious, Matthew B. Schabath, Anh Thy H. Nguyen, Nirav Shah, Shreya Mishra, Anant Kharod, Sara Khodor, Michael G. Fradley, Kerry Ellenberg, Isaac Rhea, Linh M. Duong, Justin Swanson, Kevin E. Kip
Publikováno v:
Journal of the American College of Cardiology. 73:504
Atrial fibrillation (AF) is a frequently identified cardiovascular complication affecting cancer patients. While anticoagulation (AC) is often necessary to reduce the risk of AF-associated stroke, there is little data regarding its use in cancer pati
Autor:
Chang H. Kim, Jamie Wilson, M. Khaled Sabeh, Sadeer G. Al-Kindi, Monica Lewis, Guilherme H. Oliveira, Mahmoud Farhoud, Isaac Rhea
Publikováno v:
Journal of the American College of Cardiology. 67:1897